Document Detail


Adrenoceptor-blocking activity and cardiohemodynamic effects of carvedilol in animals.
MedLine Citation:
PMID:  1696657     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The beta-blocking activities of a new beta-adrenoceptor blocking drug, carvedilol, evaluated in isolated atria and trachea of the guinea pig were 2.0 (beta 1) and 3.2 times (beta 2), respectively, as potent as those of propranolol. Carvedilol exhibited the alpha-blocking activities in the aorta of guinea pigs and rats. Carvedilol was 2 and 50 times less potent in guinea pigs and rats, respectively, than prazosin as an alpha-blocker. Thus, the alpha-blocking activities were twice as potent as the beta-blocking activity in the rat and one-fifth that of the beta-blocking activity in the guinea pig. In anesthetized open-chest dogs, the beta-blocking activity of carvedilol was 1.5 times more potent than that of propranolol and had 3.8 times the alpha-blocking activity. Thus, carvedilol is a nonselective beta-blocking drug with a potent alpha-blocking activity. Carvedilol and propranolol showed dose-dependent and significant decreases in the blood pressure, total cardiac output, left ventricular pressure, dp/dt, heart rate, coronary flow, and oxygen consumption in anesthetized open-chest dogs. Carvedilol decreased the total peripheral resistance significantly (the decrease was not proportional to the decreases in the blood pressure at high doses), while propranolol increased it significantly and dose-dependently. These results indicate the importance of alpha-adrenoceptor blocking activity in the decrease in blood pressure produced by carvedilol.
Authors:
T Kawada; T Ishibashi; M Nakazawa; S Satoh; S Imai
Related Documents :
16884657 - The latest generation of beta-blockers: new pharmacologic properties.
10696097 - Nitric oxide-dependent vasodilatation of rabbit femoral artery by beta(2)-adrenergic st...
22573127 - Twenty-four hour and early morning blood pressure control of olmesartan vs. ramipril in...
22354147 - Prevalence of residual left ventricular structural changes after one year of antihypert...
17429447 - Circulating endothelial cells in preeclampsia.
9607207 - Angiotensin converting enzyme gene i/d polymorphism in essential hypertension and nephr...
Publication Detail:
Type:  In Vitro; Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  16     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1990 Jul 
Date Detail:
Created Date:  1990-09-18     Completed Date:  1990-09-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  147-53     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Niigata University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists / pharmacology*
Animals
Aorta, Thoracic / drug effects
Carbazoles / pharmacology*
Coronary Circulation / drug effects
Dogs
Female
Guinea Pigs
Heart / drug effects*
Heart Rate / drug effects
Hemodynamics / drug effects*
Male
Muscle Contraction / drug effects
Muscle, Smooth / drug effects
Muscle, Smooth, Vascular / drug effects
Oxygen Consumption / drug effects
Propanolamines / pharmacology*
Propranolol / pharmacology
Rats
Trachea / drug effects
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Adrenergic beta-Antagonists; 0/Carbazoles; 0/Propanolamines; 525-66-6/Propranolol; 72956-09-3/carvedilol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
Next Document:  Central presynaptic alpha 2-autoreceptors are involved in the blood pressure-lowering effect of moxo...